NCT05355766View on ClinicalTrials.gov

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

September 23, 2024

Study Completion Date

March 6, 2025

Conditions

ThalassemiaIron Overload

Interventions

DRUG

CN128 Tablets

Iron chelator, oral tablets

Trial Locations (1)

Unknown

The First Affiliated Hospital Of Guangxi Medical University, Nanning

All Listed Sponsors

lead

Hangzhou Zede Pharma-Tech Co., Ltd.

OTHER